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ABSTRACT
An in Vitro Microenvironment for Nucleus Pulposus Regeneration
Mark S. Shoukry
Intervertebral disc degeneration begins early in life, increases with age, and can
ultimately result in disc failure. At the center of the disc, the nucleus pulposus (NP) resides in a
hypoxic environment where degeneration is thought to begin. Initially, nucleus pulposus cells
(NPCs) display altered morphology and function, along with increased rates of cellular
senescence and apoptosis. Though no widely accepted treatment exists, autologous NP
implantation techniques have shown promise. However, the process is flawed as a result of the
long in vitro expansion required to obtain sufficient numbers of cells. Prolonged expansion on
plastic produces negative changes such as loss of the NP phenotype and reduced redifferentiation
ability. Because cell based tissue engineering techniques require a metabolically active
population of cells, stem cells have attracted attention for regenerative NP strategies due to their
self-renewal ability and multipotent differentiation capacity. Specifically, synovium derived stem
cells (SDSCs) have a higher chondrogenic capacity compared to stem cells derived from other
tissues. Another advantage and potential use of SDSCs is that they can produce decellularized
extracellular matrix (DECM); expansion of SDSCs or NPCs on this substrate can dramatically
increase the rates of proliferation, delay senescence associated changes, and support
chondrogenic activity upon induction. In this study, it was determined that NPCs alone and
NPCs in co-culture with SDSCs can produce their own unique DECM. It was determined that
DECM properties may be modulated by varying oxygen tension during DECM deposition.
While the DECM deposited by NPCs along with SDSCs improved proliferation and guided
SDSC differentiation towards the NP lineage, the effect was greater than NPC derived DECM
and comparable to SDSC derived DECM. Normoxic conditions during DECM preparation were
more beneficial to cell proliferation, but hypoxic conditions promoted differentiation towards the
NP lineage. Finally, hypoxic conditions during pellet culture promoted NPC viability and
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The intervertebral disk (IVD) is a composite tissue consisting of three distinct regions.
Found interspaced between the bony vertebrae of the spine, the function of discs is mechanical; it
transmits loads, dissipates energy, and facilitates spinal motion. The disc undergoes profound
degenerative changes with age, the first of which occurs very early in life and can be observed
with changes in nucleus pulposus cells (NPCs)13. Disc degeneration is a downward cascade that
increases with age until almost everyone over 50 years of age is affected to some extent. Despite
often times being asymptomatic11, degeneration is often thought to be the underlying cause of
low back pain12, 26, 37, 81 and can result in more serious pathologies such as sciatica, disc
herniation 153, and prolapse146. The high frequency and increasing severity with age result in a
staggering annual cost of £12 in the United Kingdom89 and up to $200 billion in the United
States68.
Currently, there is no way to regenerate damaged disc tissue. The first stage of treatment
begins in the early phases of degeneration as pain presents. The focus is to alleviate pain and
mitigate further damage. This is accomplished pharmacologically using non-steroidal anti-
inflammatory drugs and through other interventions such as weight loss or physical therapy. If
degeneration progresses to a point where it is no longer manageable, surgery becomes the only
option. Spinal fusion is considered the standard of care and aims to prevent further degeneration
and eliminate pain by bridging adjacent vertebrae. However, it has been shown that pain often
persists and patient quality of life does not reasonably improve. Newer options such as disc
arthroplasty are still under investigation, though current results do not indicate better long term
outcomes.
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Cell based tissue engineering approaches are an area of great interest for the potential to
provide a method to repair damaged tissue. However, changes the NP undergoes with aging and
degeneration present a number of hurdles to repair strategies. These include changes in cell
phenotype, an increase in cellular senescence as well as death of the cells in the disc, and a
hostile disc environment. Consequently, autologous implantation techniques using NPCs are at a
disadvantage because the cell population is already negatively altered. To help address these
shortcomings, stem cell supplementation has shown favorable results. Additionally, the in vitro
environment represents a valuable opportunity to revitalize cells during the prolonged culture
period and to prepare them for their in vivo environment.
The aim of this study is to investigate more suitable in vitro microenvironments for NP
regeneration. The extracellular matrix (ECM) is as a potent regulator of cellular behavior and
provides many cues missing with plastic substrates. In addition to dramatically increasing
proliferation, DECM can support chondrogenic activities upon induction112. This is in agreement
with a recent hypothesis clarifying that treatment during in vitro culture is a crucial step where
essential cues are given by the microenvironment to both immediately and in the future impact
cell behavior47. The current standard microenvironment both lacks the appropriate cues and
additionally gives abnormal signals originating from the rigid plastic substrates. Because the
quality of cells used is strongly associated with outcomes in tissue engineering techniques,
developing more appropriate in vitro microenvironments is an important step for improving
outcomes.
The first hypothesis is that nucleus pulposus cells (NPCs) alone and a 50%-50%
coculture of SDSCs-NPCs can deposit DECMs to facilitate SDSC proliferation and guide
differentiation towards the NP lineage. Additionally, it was hypothesized that DECMs deposited
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under hypoxic versus normoxic conditions would facilitate chondrogenic differentiation in a
hypoxic environment. In experiment 1, DECM was produced by either NPCs, SDSCs, or a
coculture of SDSCs & NPCs. Each type of DECM was produced in both hypoxic (5%) and
normoxic (21%) conditions. Subsequently, SDSCs were expanded for one passage on each type
of DECM or plastic as a control, used to form pellets, and cultured in serum-free chondrogenic
medium for 14 days to assess differentiation.
The second hypothesis in this study is that SDSC derived DECM deposited under
hypoxia will promote NPC differentiation. In experiment 2, SDSC produced DECM under either
hypoxic or normoxic conditions and NPCs were expanded for one passage on each substrate.
Pellets from each group were formed and cultured in serum-free chondrogenic medium for 14
days in culture to assess differentiation. A summary of the study design is shown in figure 1.
Figure 1. Research design.
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Chapter 2   Intervertebral Disc Physiology
2.1 Intervertebral Disc Physiology
Found between adjacent vertebral bodies in the spine, the intervertebral disc is a
composite fibrocartilaginous tissue that acts to dissipate energy, support spinal loads, and
facilitate spinal movement. In humans, there are a total of 24 discs that are all similar in
composition and structure, but increase in size from the cervical to lumbar region74. Each disc is
formed by the NP at the center, surrounding annulus fibrosus (AF), and cartilaginous endplates
(CE) that form a boundary at the top and bottom between the disc and adjacent bony vertebral
bodies.  Nutrients to the avascular NP and inner AF are transported primarily via diffusion from
vasculature originating in the vertebral bodies that terminates at the bone-disc boundary53, 55.
Figure 2. Intervertebral discs and relation to adjacent vertebrae63.
The AF surrounds and encloses the NP. It is composed of 70% collagen33, and formed by
15-25 concentric lamellae consisting of bundles of obliquely oriented collagen I fibers that
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alternate direction between each layer83, 21. In the outer AF, the lamellae are anchored into the
adjacent vertebrae and resist excessive vertebral movement. Upon simple compression of the
IVD, the AF experiences radial bulging and tensile hoop stresses due to force transferred through
the NP’s high osmotic pressure103. The outer annulus contains the only innervations found in the
IVD85, and small vascular beds found at the dorsal and ventral AF help supply the central disc
with nutrients49, 98. While there is no distinct boundary between the AF and NP62, there is a
transition zone where proteoglycan content decreases and the predominant type of collagen shifts
from type II transition to type I33. Additionally, cells in the outer AF are elongated fibroblast-like
cells and at the center they are more rounded15.
Responsible for over one-third the total height of the spinal column143, the NP is a highly
hydrated, gelatinous structure. The NP is composed primarily of large aggregating proteoglycans
in a predominantly type II collagen network, with sparsely distributed cells responsible for
maintaining the ECM. The high water content has been recorded as composing up to 86% of
tissue mass64, and is crucial for proper tissue function since this gives the tissue its ability to
resist loading. Proteoglycans are composed of negatively charged glycosaminoglycan (GAG)
chains attached to a protein core which attract water; GAG concentration is correlated to osmotic
pressure and high osmotic pressure is essential for proper disc function115. Similar to cartilage,
the main proteoglycan is aggrecan, which is formed by the GAGs keratin and chondroitin sulfate
attached to a protein core139. Unlike similar tissues, the NP has a remarkably high ratio of
proteoglycans to collagen II of 27:1 glycosaminoglycans to hydroxyproline96. Though there are
other components present, they are only in small quantities. These include various other
collagens including types III, V, VI, IX, X, XI, XII, and XIV127 as well as other small
proteoglycans including lumican, biglycan, decorin, and fibromodulin87. Additionally, there is a
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small amount of other glycoproteins including fibronectin and amyloid. While their role is not
well understood, the minor collagens may mediate collagen type I and II fibrillogenesis127 in
addition to interactions between collagen fibrils and proteoglycans97. The adult disc is populated
and maintained by a low density (around 4,000 cells/mm3) of cells referred to as chondrocyte-
like84 or Nucleus Pulposus cells (NPCs).
2.2 Intervertebral Disc Aging and Degeneration
It is currently thought that the degenerative process is a pathological case of maturation
where normal aging associated changes take place at an accelerated rate1, 77. With both aging and
degeneration, the disc undergoes many changes in matrix structure and composition as well as in
the resident population of cells. Because of the complex mechanical interactions through which
force is transmitted between tissues in the disc, an initial disturbance in disc function trigger a
downward spiral that may culminate in total disc failure. Since these changes originate in the cell
population of the NP, the embryological origins and alterations from development to
degeneration can provide insight about which factors are important in an NP-specific culture
environment.
During development, the notochord gives rise to the immature NP which remains
populated by large, vacuolated notochordal cells142. It was initially thought that this population
of active cells disappeared or only remained at undetectable levels by the end of the first decade
of life108. However, recent evidence suggests that while changes in the population occur through
life, both populations are present well into adulthood150. The alterations in phenotype during
adolescence and adulthood have been implicated as a key instigator in the degenerative
process16, in part because notochordal cells are capable of higher rates of proteoglycans
synthesis20. Additionally, the first signs of degeneration can be detected around the same time as
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the identifiable variations in NPCs, supporting the current thought that degeneration originates in
the NP13. Though not fully understood, the disappearance of the original embryonically derived
notochordal cell phenotype may occur through autocrine or paracrine induced Fas-mediated
apoptosis70. The contribution of programmed cell death in degeneration is the result of numerous
signal transduction pathways triggered through many different stimuli156.
The in vivo disc microenvironment is considered inhospitable due to the lack of direct
vasculature. The small capillary beds that originate in the vertebral bodies and extend
superficially over the endplates55, 61 are the predominant source of nutrients and oxygen, which
must diffuse through the endplate before reaching the NP105. The only other vasculature found is
at the dorsal and ventral annulus regions, but it never extends to the nucleus pulposus49, 98.
Consequently, even in healthy disks, there are large gradients in nutrient concentration as a result
of higher rates of consumption versus diffusion from surrounding tissues29, 133. One major
problem with aging is calcification of the endplates, which places additional hurdle diffusive
transport104. The decrease in capillary buds is correlated to proteoglycan content, age, and
degeneration grade9. Finite element studies on solute transport in the disc suggest that neither
elastic modulus nor proteoglycan concentration greatly influence solute distribution, but endplate
properties including porosity, diffusion coefficient, and diffusion area are important82. Therefore,
it may be important for cell based tissue engineering strategies to be performed before endplate
calcification to optimize outcomes. The consequences of ECM degradation6, 7, 141 include fibrosis
of the NP65 and disorganization of annular lamellae80.
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Figure 3. Healthy versus degenerate intervertebral discs153.
Another important change is reduced proliferation rates in cells harvested from aged or
degenerate discs52. Increased rates of markers associated with replicative senescence18 in NPCs
include senescence associated β-galactosidase biomarker and decreased mean telomere length51,
126. Cells from degenerate discs also express various matrix degrading enzymes, a metabolic
change also characteristic of senescent cells28, 78, 151.
2.3   Current Treatment
Because many cases of IVD degeneration are asymptomatic despite some degree of
degeneration, conservative treatments to address symptoms are first used. These include
medication, physical therapy, and exercise. Should conservative treatment fails and symptoms
persist, surgical intervention becomes the only option. Spinal fusion is a widely performed
procedure that involves using an autograft to link adjacent vertebrae and consequently stabilize
the disk with the goal of eliminating pain at the cost of motion. Though it has long been the
standard treatment, its efficacy in treating discogenic low back pain has been debated and results
conflicting38, 41, 91. Total disc replacement is a newer procedure for which a number of implants
have been developed. While this procedure has shown promise, evidence regarding long term
safety and efficacy versus fusion in degenerative discs is still lacking; this procedure is generally
limited to scientific studies36, 145.  Minimally invasive NP replacement is another new technique
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employing synthetic biomaterials that has shown some potential, but investigations are still
underway30. Specifically, one promising option by Klara et al. found the device to be effective,
but 38% of patients required additional surgery due to device migration72. As a consequence of
their shortcomings and general lack of efficacy, biological therapeutic techniques aiming to
restore damaged disc tissue is a topic of great interest and promise131 as either a standalone
treatment or to supplement existing surgical procedures.
2.4 Autologous Intervertebral Disc Repair
First investigated in 196825, autologous chondrocyte implantation for cartilage defect
repair displayed positive results that were translated to clinical investigation in 199414. A recent
analysis of long-term (6-10 years) outcomes indicated sustained improvement in 69% of
patients93. Due to similarities between the NP and cartilage, investigators later began studying
autologous cell implantation techniques for IVD regeneration. One key factor in determining
therapeutic outcome is the source of cells, which can be problematic since some harvest
procedures may cause further damage, and using cells from a damaged tissue is not ideal. Cell
types investigated for autologous NP implantation include chondrocytes from articular
cartilage46, 155, NPCs39, 101, and adult stem cells.
One of the major drawbacks of using autologous NPCs is that cells derived from the
degenerate disc are not as suited for rebuilding tissue as healthy counterparts, even after
expanded to large numbers. With degeneratation, cells undergo negative morphological,
phenotypical, and metabolic alterations. These include increased numbers of cells in the process
of dying or already dead through either necrosis or apoptosis, as well as a higher frequency of
cells displaying the senescent phenotype13, 50, 126, 142. These cells display altered genotypic and
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phenotypic behavior in vitro, such as lower gene expression of critical matrix proteins and
increased catabolic matrix enzyme expression66. Suspected shortcomings of degenerate cells for
in vivo repair were verified when Hegewald et al. used cells from patients with herniated discs to
form 3D constructs and found significant signs of dedifferentiation that increased further with in
vitro expansion and a decreased ability to redifferentiate57. Therefore, for the patient population
demonstrating the greatest need, autologous NPCs may not be a viable option.
2.5 Mesenchymal stem cells in Nucleus Pulposus Regenerative Techniques
Mesenchymal stem cells possess the capacity to differentiate into various cell types
capable of creating a number of tissues19. While a variety of different cell sources have been
proposed to overcome the challenges of using degenerate NP cells, MSCs are thought to offer the
greatest potential for successful clinical application121. Most notably, MSCs were recently
successfully identified in degenerate NP and possess a capacity to differentiate towards an NP-
like lineage121. Stem cells isolated from the disc display morphological, immunophenotypical,
and differentiation criteria10, 124 typical of stem cells. However, while NP derived MSCs may
play a role in regenerative strategies in the future, their extremely limited availability and
extensive harvesting procedures make them a poor option for regenerative techniques. Their
presence does however help support the trend to use cocultures of MSCs and NPCs as a method
to specify MSC lineage in a population of MSCs isolated from various adult tissues.
Stem cells derived from the bone marrow are the most frequently used for stem cell based
NP regeneration.  The newest data supports their use in a coculture environment; stem cells exert
a positive effect on overall proteoglycan production, and NPCs may help guide MSCs towards
the NP lineage. When cultured with bone marrow derived stem cells (BMSCs), coculture with
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direct cell-to-cell contact as observed in most in vivo stem cell niches enhances the properties of
human derived BMSCs and NPCs149. Studies on cells of the NP suggests there may be a three
cell types present: notochordal cells, chondrocyte-like cells, and an NP derived stem cell
population. While their interactions are still poorly understood, in vitro experiments using
notochordal cell conditioned medium (NCCM) identified the precursor of the multifunctional
connective tissue growth factor; an increase in proteoglycan expression in NPCs occurs when
treated with NCCM. Conditioned medium additionally can support in vitro MSC differentiation
towards the NP lineage117.  This is thought to occur due to the secretion of growth factors and
soluble proteins which promote anabolic metabolism in cells as opposed to the catabolic
behavior observed during degeneration86. This evidence may additionally suggest that
notochordal cells act as regulators of NPCs.
One frequently used technique to guide MSC differentiation to the NPC lineage is
through coculture. Recently, Allon et al. developed a novel bilaminar coculture pellet system that
more closely resembles the embryonic development of the IVD4,5. When tested in vivo,
implanted bilaminar coculture cells improved both disc height and grade over time4. Their most
recent study simulating the degenerate disc environment verified the benefits of bilaminar
coculture, but did not compare the results to traditional coculture to determine whether the
bilaminar system is superior5. The BMSC-NPC coculture system has also been verified by others
to support differentiation toward an NP-like lineage102, 140.
Though BMSCs remain the most widely investigated type of adult stem cell for NP
regeneration, they may not represent the ideal source. Synovium derived stem cells (SDSCs)
have been proposed as another important candidate for NP-regeneration. The argument for
SDSCs in NP tissue engineering is similar to that for their successful use in cartilage tissue
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engineering; both the synovium and cartilage originate from a common pool of precursor cells106
and express similar link protein35 and GAG profiles54. Additionally, some comparative studies to
BMSCs have also shown SDSCs to possess a higher capacity towards chondrogenesis130, 136, 154.
All of these traits suggest they may better be suited to rebuild the degenerate cartilage-like NP.
The coculture technique has also been successfully demonstrated in SDSC-NP cultures
that produce high aggrecan and collagen type II tissue similar to that of found in the NP24.
During culture, human serum supplemented SDSCs also expand more rapidly than BMSCs100,
suggesting they may offer advantages over BMSCs for regeneration. Similar results to in vivo
BMSC studies were achieved when SDSCs were implanted in degenerate discs and found to
increase type II collagen production and suppress matrix degrading enzymes implicated in the
degenerative process92. The inhibition of catabolic enzymes and cytokines may provide a good
therapeutic target because of their association with disc degeneration151. Thus, SDSCs may offer
another good supplement of regenerative NP strategies.
2.6 The Extracellular Matrix as an In Vitro Substrate
Both in vitro and in vivo, the extracellular matrix to which cells are attached is a major
component of the microenvironment that provides signals to determine cell behavior through
both physical and biochemical interactions. The extracellular matrix is a dynamic structure that
remains active throughout life, facilitating the transmission of physiological signals though it’s
mechanical structure and chemical composition75. A primary method of cell-ECM
communications occurs via integrins, a family of transmembrane proteins operating as cell
surface receptors which connect the cytoskeleton to the surrounding extracellular matrix40.
Functioning as heterodimers, integrins are composed of an α and a β subunit; each unique
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subunit combination determines binding to specific certain ECM components. Importantly,
integrin expression is dependant on the cell type and can serve to help identify downstream
cellular responses from cell-matrix or cell-cell interactions.
Work by Nettles et al. initially identified functional integrin subunits in NP and AF, and
found discrepancies in the prevalence of subunits in each99. The primary difference was higher
expression of the α6 and β4 subunits in the NP99. The α6 subunit exists in two forms, and has
been suggested as a requirement for MSC chondrogenic differentiation132. Using flow cytometry
to quantify integrin expression levels first upon isolation and subsequently after monolayer
culture, it was found that the α6 expression was significantly higher in NPCs and that type II
collagen adhesion occurred through the α1β1 receptor, but type I collagen adhesion was only
partially mediated through this receptor. Finally, fibronectin attachment was found to occur
through the α5β1 integrin42.
In combination with β1 or β4, the α6 subunit is a primary mediator of cellular adhesion to
the extracellular matrix protein laminin, a heterotrimeric protein composed of individual α, β,
and γ chains. Currently, at least 15 identified isoforms have been identified which are expressed
differently in various tissues27, 90. In NPCs, higher expression of the α5 laminin chain, the
laminin receptors integrin subunits α3, α6, and β4 along with CD239, and CD151 were found
compared to cells from the AF23; these suggest that Laminin may be a good match for NPCs.
Gilchrist et al. examined cell-matrix interactions and found faster cell spreading and higher
risistance to detachment on laminin isoforms LM-511 and LM-332, in contrast to LM-111,
fibronectin, and collagen II44. Substrates coated with laminin softer than 720 Pa were also found
to promote in vitro proteoglycan production, cell-cell interactions, and the NP morphology43.
Unsurprisingly, the notochord from which the NP is believed to drive is a laminin rich
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structure120 and laminin coatings may one alternative to plastic substrates and promote the NP
lineage. However, these single component ECMs may not capture the needed complexity of in
vivo ECMs for regulating cell behavior. A promising alternative method that has been shown to
produce very strong positive changes in proliferation and differentiation for cartilage tissue
engineering utilizes cell produced ECM.
2.7 Hypoxia in the disc
The avascular NP129 relies on diffusion through long distances for nutrient transport; cells
must therefore be adapted for a hypoxic and nutrient deprived environment. Blood vessels from
the vertebral bodies extend across the superficial regions of endplates55. Additionally, small,
sparsely distributed vascular beds extend to the dorsal and ventral surfaces of the annulus
fibrosus but never penetrate the NP, even after major disc disruption49, 98. In agreement, oxygen
concentrations are lowest and lactate concentrations highest in the NP8.  The lack of vasculature
causes an accumulation of anerobic metabolism byproducts which produce a low pH144 and high
osmolarity71. The NP can therefore be concluded to exist in a hypoxic niche where cells express
a unique phenotype that differentiates them from those of surrounding tissues118; this phenotype
also facilitates survival and function in a hypoxic environment. In the experiments performed for
this study, we investigate the interplay between DECM and the hypoxic environment on
proliferation and differentiation toward the NP lineage.
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Chapter 3.   Materials and Methods
3.1 Isolation and culture of SDSCs and NPCs
Two three month old pigs were obtained from a local slaughterhouse and sacrificed for synovial
tissue from both knees and NP from each IVD between the lumbar vertebrae.
Synovial tissue digestion
Random tissue samples were harvested aseptically from the intimal layer of synovial
tissue from the knees of each of the three month old pigs and immediately placed in complete
medium at 4°C. The tissue was finely minced with scalpels and digested on an x-y-z shaker
(Clay Adams Nutator, BD) initially in a solution of phosphate buffered saline (PBS) from
Invitrogen containing 0.1% trypsin (Roche) for 30 minutes at 37 ºC, and subsequently in a 0.1%
collagenase P (Roche) solution with 10 U/mL hyaluronidase (Sigma) in DMEM/10% FBS, 100
U/ml penicillin, 100μg/ml streptomycin for 2 hours. To eliminate any remaining undigested
tissue, the suspension was filtered through a 70μm nylon filter. Cells were plated in complete
medium [αMEM containing 10% fetal bovine serum (FBS), 100 U/ML penicllin, 100 μg/mL
streptomycin, and 0.25 μg/mL fungizone (Invitrogen)]. Medium changes were performed every
two days to remove nonadherent cells.
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Figure 4. Synovial tissue layers in the knee joint110
Nucleus Pulposus digestion and NP isolation
The harvested NP tissue was digested using a solution of 0.1% collagenase A (Sigma, St.
Lous, MO) and 10 U/mL hyaluronidase (Sigma) in DMEM containing 10% FBS for 4 hours at
37 ºC. Any remaining undigested tissue was removed by filtering through a 70μm nylon filter.
Cells were plated in complete medium and medium changes were performed every two days to
remove nonadherent cells.
3.2 Negative Isolation and of SDSCs
The SDSCs were negatively isolated from primary cultures of adherent synovial cells
composed of both macrophages and fibroblasts109, 113, 157 by first detaching cells by trypsinization
(0.25% trypsin/0.2% EDTA) for no longer than 2 minutes. After washing, cells were suspended
in PBS/2% FBS (107/ml) and incubated with 5x107/mL Dynabeads® M-450 CD14 containing a
monoclonal antibody specific for macrophages (Dynal Biotech, Oslo, Norway) at 4°C for 1 h.
The conjugated cells and unbound Dynabeads® were collected using the Dynal Magnetic Particle
Concentrator® (Dynal Biotech, Oslo, Norway). The now depleted supernatant with synovial
fibroblasts (referred to as SDSCs8) was saved for further passaging.
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3.3   Gelatin Surface Preparation
This procedure was performed for all DECM groups before seeding cells. Plastic flasks
were first coated with 0.2% gelatin (Sigma, St. Louis, MO) and placed in 37ºC incubators for 1
hour. The gelatin solution was aspired and the surface washed with PBS. The flasks were then
coated with a 1% glutaraldehyde solution and allowed to rest at room temperature for 30
minutes. Next, flasks were washed 3 times for 5 minutes each, coated with 1M ethanolamine
solution, and allowed to rest at 37ºC for 30 minutes. The flasks were again washed 3 times for
one hour.
3.4 DECM Production
Passage 3 SDSCs for S.DECM or passage 1 NPCs for N.DECM were plated at 6,000
cells/cm2. Co-culture ECM was produced by seeding 3,000 cells/cm2 SDSCs with 3,000
cells/cm2 NPCs. Until reaching 90% confluence, all groups were placed in 21% O2 incubators.
Medium changes were performed every two days (complete medium). Upon reaching 90%
confluence, the complete medium was supplemented with 50 μM of L-ascorbic acid (Wake
Chemicals USA Inc., Richmond, VA) and one group was left in the 21% O2 incubator while
another was transferred into a 5% oxygen (hypoxia) incubator for 8 days during DECM
deposition. Finally, each group was incubated with 0.5% Triton X-100 containing 20 mM
ammonium hydroxide at 37ºC (in the same oxygen concentration incubator as during ECM
production) for an average of 4 minutes to remove cells. The DECMs in each group were stored
at 4ºC in PBS containing 100 u/mL penicillin, 100 μg/mL streptomycin and 0.25 μg/mL
fungizone.
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Experiment 1 Part 1: SDSCs passaged on SDSC, NPC, or SDSC-NPC DECM in hypoxia
In this experiment, there were a total of 7 experimental groups. Passage 3 SDSCs were
seeded at a density of 3,000 cells/cm2 for one passage onto N.DECM, Co.DECM, or S.DECM, at
either 21% or 5% oxygen. After 1 passage, cell counting was performed and pellets were created.
Following overnight incubation, pellets were treated with condrogenic medium and maintained
at 5% oxygen for the remaining 14 days in an incubator.
Experiment 2 Part 1: NPCs cultured on SDSC-ECM deposited under hypoxia
In this experiment, there were a total of 6 experimental groups. Passage 1 NPCs were
seeded onto S.DECM  deposited at either normal (21% O2) or hypoxic (5% O2) conditions.
Subsequently, passage 1 NPCs were seeded at a density of 3,000 cells/cm2 for one passage on
each type of DECM. Finally, after pellets were created and following overnight incubation were
treated with chondrogenic medium and maintained at either 21% or 5% oxygen for the remaining
14 days in an incubator.
Experiments 1&2 Part 2: Pellet Culture and Chondrogenic Differentiation
After in vitro expansion, 0.3x106 cells from each pretreatment were centrifuged at 500 g
for 7 min in 15-mL polypropylene tubes to form cell pellets. Following overnight incubation,
pellets were cultured in serum-free chondrogenic medium containing high-glucose DMEM, 40
μg/mL praline, 100 nM dexamethasone, 100 U/mL penicillin, 100 μg/mL streptomycin, 0.1 mM
ascorbic acid-2-phosphate, and 1 x ITSTM Premix (6.25 μg/mL insulin, 6.25 μg/mL transferring,
6.25 μg/mL selenous acid, 5.35 μg/mL linoleic acid and 1.25 μg/mL bovine serum albumin from
BD Biosciences, Bedford, MA) with supplementation of 10 ng/mL transforming growth factor
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beta3 (TGF-β3, PeproTech Inc., Rocky Hill, NJ) for 14 days. Pellets were collected at days 0, 7,
and 14 for chondrogenic evaluation.
3.5   Histochemistry and immunochemistry
Randomly selected pellets (n=3) from each data point were first fixed in a 4%
paraformaldehyde solution at 4ºC overnight. Samples were embedded in paraffin and 5μm
sections were cut.  Successive segments were stained with safranin O/fast green for sulfated
GAG and immunostained with monoclonal antibodies against collagen I (Sigma) and collagen II
[II-II6B3, Developmental Studies Hybridoma Bank (DSHB) Iowa City, IA], collagen I (Sigma).
Immunohistochemical sections were hydrated, treated with 1% hydrogen peroxide to inhibit
endogenous peroxidase, and incubated first for 30 minutes with 2 mg/mL testicular
hyaluronidase in phosphate-buffered saline (pH 5) at 37ºC, another 30 minutes with 1.5% normal
horse serum, and finally overnight at 4ºC with the primary antibody. A secondary antibody of
biotinylated horse anti-mouse IgG (Vector, Burlingame, CA) was incubated on sections for 30
minutes). Immunoactivity was detected using the Vectastain ABC reagent (Vectastain ABC,
Burlingame, CA) with 3-3’-diaminobenzidine (DAB, 0.05%) and hydrogen peroxide (H2O2,
0.015%) as a substrate with hematoxylin (Vector) as a counterstain.
3.6 Biochemical analysis for DNA and GAG content
The pellets (n=4) were digested for 4 hours at 60°C with 125 μg/mL papain in PBE
buffer (100 mM phosphate, 10 mM EDTA, pH 6.5) containing 10 mM cysteine. Each sample
was digested using 100 μL of enzyme. Quantification of cell density was accomplished by
measuring the amount of DNA in the papain digestion using a QuantiTTM PicoGreen® dsDNA
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assay kit (Invitrogen, Carlsbad, CA) with a CytoFluor® Series 4000 (Applied Biosystems, Foster
City, CA). The GAG content was measured using dimethylmethylene blue dye and a
SpectronicTM BioMateTM 3 Spectrophotometer (Thermo Scientific, Milford, MA) with bovine
chondroitin sulfate from Sigma as a standard.
3.7   TaqMan® Quantitative PCR
The total RNA was extracted from samples (n=4) using an RNase-free pestle in TRIzol®
(Invitrogen). One µg of mRNA was used for reverse transcriptase (RT) with a High-Capacity cDNA
Archive Kit at 37ºC for 120 min as recommended by the manufacturer (Applied Biosystems).
Chondrogenic marker genes [collagen II (Col II) (Assay ID: AIJ9V6I)] and hypertrophic genes [collagen
X (Col X) (Assay ID: AI382VX) and alkaline phosphatase (ALP) (Assay ID: AI1Q8RQ)] were
customized by Applied Biosystems as part of the Custom Taqman® Gene Expression Assays. Eukaryotic
18S RNA (Assay ID: HS99999901_s1 ABI) was carried out as the endogenous control gene. Real-time
PCR was performed with the iCycler iQTM Multi Color RT-PCR Detection System and calculated by
computer software (Perkin-Elmer, Waltham, MA). Relative transcript levels were calculated as χ=2-ΔΔCt,
in which ΔΔCt=ΔE-ΔC, ΔE=Ctexp-Ct18s, and ΔC=Ctct1-Ct18s.
3.8 Statistics
The Kruskal-Wallis test was used to test for significant differences among all groups and
the Mann-Whitney U test was used for pairwise comparison in biochemistry analysis and real-
time PCR data. All statistical analyses were performed with SPSS 13.0 statistical software (SPSS
Inc., Chicago, IL). P values less than 0.05 were considered statistically significant.
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Chapter 4   Results
(Partially adapted from Pei M, Shoukry M, et al.114)
4.1   Experiment 1: SDSC expansion on DECM (Figure 5A & B)
To determine the feasibility of varying oxygen tension as a method of modulating DECM
properties, S.DECM, N.DECM, and Co.DECM were prepared under either normoxic or hypoxic
conditions. For one passage, SDSCs were cultured on each substrate and plastic to serve as a
control. After 5 days, cell numbers were used to assess the effect of each DECM on SDSC
proliferation (Figure 5A). It was found that the effect of hypoxia or normoxia produced DECM
on SDSC numbers after 1 passage was not significant, but all DECMs greatly enhanced
proliferation compared to plastic controls. The highest cell numbers were recorded by S.DECMs.
Pronounced morphological changes in cell shape and organization were observed in DECM
groups relative to plastic (Figure 5). Namely, plastic expanded cells became large and flattened
while DECM expanded cells became small and spindle shaped. Additionally, cell density
remained similar between days 3 and 5 on plastic while dramatic increases were observed in
DECM groups. In DECM groups, cells were also observed to propagate along DECM fibers and
can be seen to above and below other cells, while propagation in plastic appeared limited to the
2D substrate.
4.2   Experiment 1: Histology and Immunostaining (Figure 5C)
Differentiation potential was assessed after one passage on each type of DECM using
pellet culture for fourteen days in serum-free chondrogenic medium supplemented with TGF-ß3.
The results of staining for collagen type I, type II, and GAGs are displayed in Figure 5 below.
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After 14 days, DECM expanded SDSCs produced larger pellet sizes than plastic. In all DECM
expanded groups, intense staining was observed for sulfated GAGs by both Alcian blue and
Safranin O staining. Immunostaining for collagen II was stronger and more homogenous in
hypoxic versus normoxic cultures, most notably in the center of pellets. Only minimal staining
for collagen, either type I or II, was observed in the plastic group. Finally, immunostaining for
collagen I was also stronger in DECM groups than plastic, though 5% S.DECM appeared to have
the lowest levels among DECM groups, with the exception of the 5% Co-culture group that was
similar.
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Figure 5. The proliferation rates and chondrogenic potential were improved after DECM
expansion. (A) Passage 3 SDSCs were expanded on seven substrates for one passage. Cell
number was quantified using a counting hemocytometer from four 175 cm2 plastic flasks in each
group; (B) Cell morphology at days 3 and 5 during expansion; and (C) Expanded cells were
cultured in a serum-free chondrogenic medium in a pellet system for 14 days. Alcian blue and
Safranin O staining were used to detect sulfated GAGs. Immunostaining was used for collagens I
and II. The scale bar is 800 µm.
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4.3   Experiment 1: Biochemical Assessment (Figure 6A)
Relative DNA contents were calculated by dividing the DNA content at a given time
point (i.e. days 7 and 14) by that of day 0 to facilitate comparison between groups. At day 7,
S.DECM, CO.DECM, and plastic all remained at similar levels. Both N.DECM groups were also
at a similar level, with the hypoxic the N.DECM group at a slightly (statistically significant)
lower level. Ratios dropped by day 14 and any significant inter-group variance was eliminated,
showing that viability was maintained well in all groups regardless of DECM pretreatment.
Relative GAG content (GAG index) was adjusted by dividing the GAG content at a time
point by the DNA content at that time point, providing a comparable measure for variation in
GAG content between groups after adjusting for differences in DNA content. At day 0, all
groups were at a minimal level. By day 7, all DECM groups had a higher total GAG content and
GAG index than the plastic control. The highest total GAG content at this time point was in the
normoxic CO.ECM and S.ECM groups, but after adjusting for DNA the difference became
minimal. The trend continued at day 14 where absolute GAG content was again highest in the
normoxic CO.DECM and S.DECM groups, but after adjusting for DNA, variation became
minimal. The plastic group remained at a very low level compared to DECM groups.
4.4 Experiment 1: Messenger RNA Analysis (Figure 6B)
Since the major type of collagen in the disc is type I, variability in the properties of
DECMs created as a result of either the cell type that produced them or environment in which
they were produced, the effect on this gene was examined. All DECM groups exhibited collagen
II mRNA levels many times higher than plastic. No statistical difference was observed between
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both N.DECM, S.DECM, and CO.DECM groups. However, both hypoxic and normoxic
N.DECM groups were at the lowest level among DECM groups.
The hypertrophic markers used were collagen X since it signifies late-stage chondrocyte
hypertrophy 119, 95 and alkaline phosphatase for key roles in mineralization60, 45.  Plastic yielded
significantly higher mRNA levels of collagen X than either of the CO.DECM and S.DECM
groups, but similar levels to both N.DECM groups. In contrast, plastic produced the lowest ALP
mRNA levels. Among DECM groups, the lowest significant levels were in S.DECMs and the
highest level was found in the normoxic N.DECM group.
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Figure 6. Expansion on DECM improved both SDSC viability and chondrogenic capacity in a
pellet culture system. (A) Biochemical analysis for DNA and GAG contents in a pellet. Cell
viability is shown with either day 7 or day 14 DNA ratios adjusted by day 0. Chondrogenic index
assessed using the ratio of GAG to DNA. (B) Real-time PCR was used to assess chondrogenic
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differentiation at the mRNA level. Collagen II (Col II) mRNA was a marker for chondrogenic
differentiation; collagen X (Col X) and ALP mRNAs were used as markers for hypertrophy.
Lower case letters (i.e., a, b, and c) indicate the results of one-way analysis of variance
(ANOVA) at p < 0.05. Groups with a letter in common are not statistically different from one
another. Error bars represent the mean  SD for n=4.
4.5   Experiment 2: NPC expansion on DECM (Figure 7A)
In this experiment, NPCs were expanded for 1 passage on SDSC produced DECM. To
determine if DECM can be customized during the deposition phase, DECMs were produced in
either a hypoxic (5% O2) or normoxic (21% O2) culture environment. Finally, pellets were
additionally cultured during chondrogenic differentiation in either 21% or 5% oxygen to assess
the effects on matrix production. Gross observation in Figure 7A shows cell density to be
drastically higher in DECM groups and a change in morphology to a smaller, thin shape.
Additionally, cells propagated along DECM fibers and in a 3D arrangement while plastic
cultured cells only propagated along the 2D substrate and remained widely distributed.
4.6   Experiment 2: Histology and Immunostaining (Figure 7B)
Gross pellet characteristics were similar to those observed in the previous experiment,
showing much larger pellet sizes in all DECM groups. Surprisingly, collagen II immunostaining
showed that plastic treated cells produced pellets with collagen II content comparable to DECM
groups. Also, the hypoxic S.DECM differentiated in hypoxia produced the lowest observable
levels of collagen II. Collagen type I immunostaining was similarly low in all groups. Staining
for GAGs indicated similar levels among groups.
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Figure 7. DECM expansion enhanced NPC proliferation and redifferentiation capacity. (A)
Passage 2 NPCs were expanded on three substrates for one passage. Cell morphology was
photographed at day 3 and day 5 during expansion. (B) Expanded cells were cultured in a serum-
free chondrogenic medium in a pellet system for 14 days. Alcian blue and Safranin O staining
were used to detect sulfated GAGs. Immunostaining was for collagens I and II. The scale bar is
800 µm.
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4.7   Quantitative Biochemical Assessment (Figure 8A)
At day 7, all DECMs produced higher cell numbers and a significant difference between
Hypoxic and Normoxic DECMs was observed. Among groups, 5% Hypo.DECM produced the
highest numbers. By day 14, this difference between the Norm. and Hypo.DECMs became
negligent, but cells differentiated in 5% oxygen maintained the highest numbers assessed by
DNA content.
The total GAG content followed a similar trend to that of DNA. Specifically, the 5% O2
differentiation environment produced the highest GAG content at day 14, but after accounting
for DNA content changes, both Norm. and Hypo.DECM produced similar higher levels than
other groups. While all DECM groups produced significantly higher levels than plastic, 21%
Norm. and Hypo. DECM groups produced lower levels than 5% Norm. and Hypo.DECMs.
4.8    Messenger RNA Analysis (Figure 8B)
The highest levels of relative collagen II mRNA were found in the 5% pellets/
Hypo.DECM. While 5% pellets had similar levels for both Norm.DECM and Hypo.DECM,
there was a large significant difference between the two DECMs when pellets were cultured
under 21% O2. The lowest values were found in the 21% plastic group.
The highest levels of both hypertrophic markers were found in the 5% S.DECM groups.
Both plastic groups produced the lowest relative mRNA levels of Col X mRNA and the 21%
plastic group produced the lowest relative mRNA levels of ALP. Both 5% DECM groups had the
highest collagen X and ALP levels.
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Figure 8 DECM expansion enhanced NPC viability and redifferentiation capacity in a pellet
system. (A) Biochemical analysis was used to measure DNA and GAG contents in a pellet. Cell
viability was reflected by DNA ratio at day 7 or day 14 adjusted by day 0. Chondrogenic index
was evaluated by ratio of GAG to DNA. (B) Real-time PCR was used to assess NPC
redifferentiation at the mRNA level. Collagen II (Col II) mRNA was a marker for chondrogenic
31
differentiation; collagen X (Col X) and ALP mRNAs were used as markers for hypertrophy.
Lower case letters (i.e., a, b, and c) indicate the results of one-way analysis of variance
(ANOVA) at p < 0.05. Groups with a letter in common are not statistically different from one
another. Error bars represent the mean  SD for n=4.
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Chapter 5: Discussion
(Partially adapted from Pei M, Shoukry M, et al. and Shoukry M, Pei M, et al. [submitted])
5.1 Overview
Current autologous nucleus pulposus implantation techniques have failed to achieve
success rates and levels necessary for clinical use. These limitations are thought to be the result
of the cell population; inadequate monolayer culture environment tends to negatively impact
cells with increasing expansion time. There is increasing evidence that suggests pretreatment
with the correct conditions during expansion can produce a cell population with greater in vivo
success34,58,88; this is of particular importance in the IVD due to the hostile microenvironment.
When passaged in monolayer on plastic, NPCs are known to proliferate slowly147 and undergo
increasing dedifferentiation57. Cells from the degenerate NP also become increasingly senescent,
which makes them minimally responsive to growth factor or cytokine stimulation. They also
display a catabolic metabolism characterized by the increased production of matrix degrading
enzymes126, 69, 28. Similarly, adult stem cells undergo analogous negative changes with time in
two-dimensional (2D) monolayer culture. In this investigation, we explored the use of various
DECMs to facilitate both SDSC differentiation and NP redifferentiation toward the NP lineage.
The avascular NP129 relies on diffusion through long distances for nutrient transport; cells
must therefore be adapted for a hypoxic and nutrient deprived environment. Blood vessels from
the vertebral bodies extend across the superficial regions of endplates55. Additionally, small,
sparsely distributed vascular beds extend to the dorsal and ventral surfaces of the annulus
fibrosus but never penetrate the NP, even after major disc disruption49, 98. In agreement, oxygen
concentrations are lowest and lactate concentrations highest in the NP8.  The lack of vasculature
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produces the accumulation of anerobic metabolism byproducts which produce a low pH144 and
high osmolarity71. The NP can therefore be concluded to exist in a hypoxic niche where cells
express a unique phenotype that differentiates them from those of surrounding tissues118.
Because the hypoxia is also associated with inhibition of cellular senescence152, it is of unique
importance for cell based NP regeneration techniques, especially those using stem cells.
Sufficient and high-quality cells, either tissue-specific SDSCs or NPCs, are critical for
the success of cell-based NP tissue engineering and regeneration. Our current study
demonstrated that DECM deposited by SDSCs, NPCs, or a combination could provide a robust
cell expansion system for SDSC proliferation. However, S. DECM provided the highest mitotic
effect. Compared to cells expanded on plastic, DECM expanded SDSCs also exhibited a strong
chondrogenic differentiation capacity, particularly for S.DECM and CO.DECM. Intriguingly,
DECM prepared under normoxia yielded SDSCs with higher cell viability and chondrogenic
index but it was not a significant difference compared to hypoxia. DECM deposited by SDSCs
was chosen for Experiment 2 due to its robust cell expansion and chondrogenic capacity. We
found that DECM prepared under hypoxia favored NPC viability and GAG production as well as
collagen II mRNA expression and decreased NPC hypertrophy, as evidenced by lower mRNA
levels of collagen X and ALP. Moreover, low oxygen in a pellet culture system dramatically
enhanced NPC viability and redifferentiation capacity.
5.2 Experiment 1 Discussion
In experiment 1, SDSCs were expanded for one passage on S.DECM, N.DECM, or
Co.DECM, or plastic; each DECM was produced by cells under either normoxic or hypoxic
conditions. After one passage, cell counting demonstrated that the highest SDSC numbers were
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produced by the normoxia and hypoxia produced S.DECMs, with the hypoxia produced
S.DECM producing slightly higher numbers. After 14 days of pellet culture under hypoxic
conditions in serum free chondrogenic medium, RT-PCR analysis showed the highest total GAG
production for normoxic CO. and S.DECMS, but variability was diminished after accounting for
DNA content. Because DNA content provides a measure of cell numbers, day 14 results indicate
that the higher absolute GAG contents are a result of higher cell numbers. Both N.DECM groups
produced the lowest levels of collagen type II and GAG mRNA at day 14, suggesting that
N.DECM may not be a good option as part of the in vitro environment for SDSCs. The relative
mRNA contents of collagen type X, a marker of undesirable terminal differentiation was at the
lowest levels for both CO.DECM and S.DECM groups. Additionally, ALP levels indicative of
undesirable mineralization were lowest at the same level for both S.DECM groups. In this
experiment, only 5% oxygen during SDSC differentiation in pellet culture was applied since this
reflects the environment in vivo and is in agreement with experiment 2 where NPC
redifferentiation occurs best under hypoxic conditions.
Especially for MSCs which may not express traits necessary for survival and proper
function in a low oxygen environment, hypoxic preconditioning may provide a good strategy.
When treated with hypoxia, MSC viability is increased and rates of apoptosis are decreased post-
implantation116. One mechanism this occurs is through HIF-1α22 expression which is continually
expressed in NP cells and may therefore provide a good method to both enhance post
implantation survival and prime cells for differentiation towards an NP like lineage. Because
gene expression and metabolic activity of cells cultured in hypoxia is different compared to cells
under normal oxygen tension, we hypothesized in this experiment that hypoxic DECM would
favor NPC redifferentiation. Our results indicated that the two types of DECM impacted NPCs
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differently with respect to GAG mRNA expression. This suggests that hypoxic DECM varies in
either composition or structure.
Another other interesting finding in this experiment was that DECM deposited by a
coculture of NPCs and SDSCs produced almost the same results as DECM deposited by SDSCs
alone. In contrast, while NPC deposited DECM provided a much improved substrate compared
to plastic, it ranked lowest among other DECM groups. A reasonable assumption is that all cells
during culture are active producers of DECM. Therefore, a reasonable conclusion is that SDSCs
were able to favorably and significantly impact NPC behavior to produce a DECM with almost
the same properties as SDSC only produced DECM. These results suggest that NPCs and SDSCs
are able to work together well in a culture environment, and more importantly, that SDSCs may
play an important role in reprogramming NPCs. These results support analogous findings where
transplanted SDSCs suppressed MMP gene activity NP cells92 and taken together suggest that
SDSCs coculture may be a useful tool in influencing NPC behavior while creating a tissue
specific microenvironment. However, further studies are needed to uncover the underlying
mechanism for SDSC regulation of NPC behavior.
5.3 Experiment 2 Discussion
In experiment 2, NPCs were expanded for one passage on S.DECM produced under
either hypoxic or normoxic conditions, then cultured in serum free chondrogenic medium under
either hypoxic or normoxic conditions. At day 14, the highest absolute GAG content was
observed in the Hypo.DECM and 5% during pellet culture. After accounting for DNA content,
the difference was maintained, though only by a slight margin after accounting for error. This
group also displayed the highest levels of relative collagen II mRNA. While the levels of
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collagen type X mRNA at day 14 were similar for both 5% pellet culture groups, ALP mRNA
was lower for ALP mRNA. Importantly, ALP provides a measure of mineralization which is
undesirable for the NP. Therefore, for NPCs, hypoxia during SDSC depositition of DECM
additionally functions with hypoxia during redifferentiation. This is an important finding because
it indicates better overall tissue quality and cell viability under hypoxic conditions, similar to
those found in the native NP and may produce higher quality tissue in vivo.
Together, these results have important implications for autologous NP implantation
techniques. If NPCs remain as the chosen cell source for autolgous techniques, then it is
suggested that the required in vitro expansion should incorporate DECM as a key component of
the in vitro expansion microenvironment. In agreement with a recently published concurrent
study from our lab, SDSC deposited DECM has a very strong beneficial impact on NPCs. This
includes dramatically increased proliferation ability for at least 6 passages in vitro and
upregulation of key gene expression including collagen type II, aggrecan, and Sox 956.
Additionally, this study by He et al. found an increase in CD90 expression. As a stem cell
surface marker positively related to immunosuppressive capacity117, higher CD90 expression
suggests DECM may also promote the reprogramming of cells with immunosuppressive traits.
In this experiment we additionally demonstrated that the DECM properties may further
be attenuated using hypoxia to increase GAG production. Additionally, DECM deposited under
hypoxia resulted in lower ALP expression that DECM deposited under normoxia, suggesting an
additional impact on undesirable mineral deposition during differentiation. Unfortunately, NPC
expansion on NPC deposited DECM could not be evaluated due to study size. However, a
similar recent study in chondrocytes comparing chondrocyte deposited DECM with SDSC
deposited DECM on chondrocyte expansion and redifferentiation indicated that SDSCs can
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produce the best substrate111. Similarities between chondrocytes and NPCs might suggest that the
results would be similar in NPCs, but this has yet to be investigated. Additionally, DECM in this
study was deposited under normoxia, so the beneficial effects of hypoxia during DECM
deposition have yet to be verified. Additionally, while speculation can be made regarding the
mechanisms underlying hypoxia induced DECM differences; further study is needed to reveal
them.
5.4 Mechanisms Underlying Hypoxia
The effects of hypoxia are regulated by the hypoxia inducible factor (HIF) group of
transcription factors, whose family of HIF target genes regulates key cellular functions, including
energy metabolism, angiogenesis, cell survival, apoptosis, matrix synthesis, proliferation, self-
renewal, and differentiation123. Serving as the key regulator of energy metabolism and survival,
HIF-1 is a heterodimer consisting of an α and a β subunit, with the former degrading quickly
under normoxic conditions134, 148. Another key isoform, HIF-2α, has some common action with
HIF-1 but also serves as a regulator for genes unresponsive to HIF-179. The response to HIF-1
and HIF-2 are cell specific. For example, only HIF-2 was found to be a regulator of Sox9 in
chondrocytes76, but the hypoxic response of BMSCs includes HIF-1α regulation of the same
gene67,28. Therefore, the combined action of HIF-1 and HIF-2 is considered to be dependant on
cell type 138.
A central function of HIF-1α is in promoting transcription of glycolytic enzymes
essential for cells to switch from aerobic to anerobic metabolism134, 135 in part by inhibiting ATP
production through oxidative phosphorylation107. One unique trait of NPCs is the continued
expression of HIF-1α under normoxic conditions, whereas in other cell types this isoform is
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quickly degraded125. Known to be involved controlling mineralization in various tissues
including bone, the calcified zone of the growth plate, and the degenerate NP, ANK expression is
negatively regulated by both HIF-1 and HIF-2 in the NP and is thought to prevent mineralization
under physiological conditions 137. A decrease in aggrecan expression is also observed upon HIF-
1 inhibition, suggesting the unique oxygen-independent stabilization of HIF-1α is an important
metabolic adaptation for both glycolysis and aggrecan expression3. This finding further supports
the recent report that NPC metabolism is not reduced at O2 concentrations as low as 1% and that
the hypoxic environment positively impacts aggrecan production while promoting a healthy
gelatinous as opposed to fibrous matrix94.
Additionally, HIF-2 also was found to regulate the p300 binding protein cited2 which
regulates both HIF-1 and HIF-2 dependent vascular endothelial growth factor (VEGF)
expression in NPCs2. Another key consequence of the low oxygen environment in NP cells is
promoting the expression of proteins responsible for Notch signaling, an important regulator of
proliferation59. Hypoxic activation of the PI3K/Akt and MAPK pathways is thought to underly
the downregulation of apoptosis in healthy NP cells in a hypoxic, serum deprived
environment122. Hypoxia also induces expression of the Notch gene related to maintaining an
undifferentiated state and cell fate determination73, 48. These mechanisms may have played a role
in producing the variation in DECM properties observed in this study, but further studies are
needed to determine the specific response. The significant positive results suggest that SDSC
DECM may have important utility as a biomaterial for NP tissue engineering. It is suggested that
the first step in developing this technology for future use is characterizing the composition and




As a substrate for in vitro expansion, DECM provides a highly superior surface that
drastically increases proliferation and strengthens both stem cell differentiation towards the NP
lineage and NP redifferentiation. Additionally, these beneficial effects can be mediated by
hypoxia. This suggests that in the future, growth factors might be used in an analogous fashion to
further customize DECMs. The requirement for high numbers of metabolically active cells for
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